Devdatt Kurdikar Embecta Corp. (EMBC) insider trading activity

Devdatt Kurdikar is President and CEO of Embecta Corp.. Currently has a direct ownership of 499,582 shares of EMBC, which is worth approximately $5.94 Million. The most recent transaction as insider was on Apr 04, 2025, when has been sold 39,592 shares (Common Stock) at a price of $12.0 per share, resulting in proceeds of $475,104. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 500K

5.96% 3M change

28.76% 12M change

Total Value Held $5.94 Million

Devdatt Kurdikar Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 04 2025	SELL Payment of exercise price or tax liability	$475,104 $12.0 p/Share	39,592 Reduced 7.34%	499,582 Common Stock
Nov 26 2024	SELL Payment of exercise price or tax liability	$915,477 $18.7 p/Share	48,956 Reduced 8.44%	531,239 Common Stock
Nov 26 2024	BUY Grant, award, or other acquisition	-	187,166 Added 24.39%	580,195 Common Stock
Apr 04 2024	SELL Payment of exercise price or tax liability	$57,957 $12.78 p/Share	4,535 Reduced 1.16%	388,005 Common Stock
Feb 11 2024	SELL Payment of exercise price or tax liability	$279,102 $16.26 p/Share	17,165 Reduced 4.22%	389,940 Common Stock
Nov 26 2023	SELL Payment of exercise price or tax liability	$322,358 $17.49 p/Share	18,431 Reduced 4.35%	405,034 Common Stock
Nov 26 2023	BUY Grant, award, or other acquisition	-	178,674 Added 29.67%	423,465 Common Stock
Aug 10 2023	BUY Open market or private purchase	$109,050 $21.81 p/Share	5,000 Added 2.0%	244,791 Common Stock
Apr 04 2023	SELL Payment of exercise price or tax liability	$133,380 $27.36 p/Share	4,875 Reduced 2.0%	239,451 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$60,127 $28.51 p/Share	2,109 Reduced 0.86%	244,326 Common Stock
Nov 26 2022	SELL Payment of exercise price or tax liability	$146,301 $33.04 p/Share	4,428 Reduced 1.77%	246,435 Common Stock
Nov 26 2022	BUY Grant, award, or other acquisition	-	83,233 Added 24.91%	250,863 Common Stock
Apr 04 2022	BUY Grant, award, or other acquisition	-	91,171 Added 50.0%	91,171 Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director